Pnet, South Africa’s leading online recruitment platform, welcomes Finance Minister Enoch Godongwana’s commitment to reforming South Africa's national skills ecosystem in today’s Budget Speech. It was ...
As businesses look to retain and attract skilled workers, they are shifting toward integrating better benefits—such as training, development, and rewards—into pay packages alongside salary hikes.
Pnet, South Africa’s leading online recruitment platform, has released its Pnet Job Market Trends Report, including the 2026 Salary Guide. This essential analysis offers salary ranges for more than ...
Pnet has released its Job Market Trends Report for January 2026, which highlights average salary ranges for various jobs in South Africa. The firm’s 2026 Salary Guide features up-to-date salary ...
Online recruitment firm Pnet has published its 2026 Job Market Trends Report, which includes salary guides and ranges for various jobs in South Africa. The group’s analysis covers salary ranges for ...
Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...
PNETs are classified as functional or non-functional, influencing symptoms and treatment strategies. Tumor grade impacts prognosis and treatment plans. Diagnosis involves imaging, blood tests, and ...
A startling milestone has been reached in Florida's war against the invasive Burmese pythons eating their way across the Everglades. The Conservancy of Southwest Florida reports it has captured and ...
10-year follow up of a phase 2 clinical trial of pembrolizumab (pembro) in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors. This is an ASCO Meeting ...
Peripheral primitive neuroectodermal tumors (pPNETs) are small embryonic carcinomas that develop in the soft tissue and bone, away from the central nervous system (CNS) and sympathetic nervous system ...
Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine tumors. Patients treated for advanced neuroendocrine tumors (NETs) are at ...
The US Food and Drug Administration (FDA) has approved cabozantinib (Cabometyx, Exelixis, Inc.) for certain adults and children aged ≥ 12 years with previously treated, well-differentiated pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results